After evaluating in vitro targeting ability of LyP-1, the localization of LyP-1-FITC in tumor tissues was analyzed by the immunofluorescence method, and the imaging efficacy of 99mTc-LyP-1 was further confirmed in vitro and in a TNBC tumor-bearing mouse model. Here, PTPN22 is linked to neoplasm.